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bacterial antigens characterized recently, some induce highly specific 
skin test results in animals. The aim of the present study is to 
investigate the ability of secreted aiitigens from M .  tuberculosis 
(ESAT6, MPT63, MTC28) and an M. avium antigen (niig) to elicit 
specific human T-cell reactions in vitro 
Methods: PPD and antigens from M.  rubercirlosic and M.  a v w n  
were an'ilyzed by lymphocyte proliferation and IFN-g secretioi~ of 
mononuclear cells obtained from imniunocoinpetrnt patients (below 
30 years of age) with culture-proven tuberculosis (TB, n=15)  o r  121. 
aviuni infection (MAI, n=6) 
Results: In TB patients, lymphocyte proliferation (S13) was 
observed in 75% for ESAT6, 27% for MPTh3, 50% for MTC28 and 
78% for a cocktail of these antigens. Thirtythree per cent of TB 
patients also reacted to inig; all recoguized PPD. In the MA1 group, 
mig elicited responses in 50%. and PPD in 67%. Neither ESAT6 nor 
MPT63 were recognized in vitro by these patients, while MTC28 
and the cocktail induced a reaction in one patient. Healthy coiitrols 
showed coinparable result5 to the MA1 group, but no proliferation to 
PPD 
Conclusions: Our data indicate that single secreted M.  ~uberctrlosis 
antigens allow differentiation of M.  luberculosis and M. aviurn infection 
with a higher specificity than PPD. However, single antigens might 
not be sensitive enough for clinical diagnostic purposes, where 
defined antigen cocktails could be of advantage 
Optimal in vitro growth conditions for 
Mycobacterium genavense 
L. Realini', K. De Ridder ', B. Hirschel', E Portaels'. 'Institute qf 
%pica1 Medicine, Antwerp, &&$IIWI; 'University Hospital, Geneva, 
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A4ymbart~riu~t~ p m u r r i s e  was first described in 1990 and was accepted 
as a novel species in 1993. This mycobacterium is responsible for 
infections in animals (birds and dogs) and humans (AIDS and non- 
HIV individuals). M. pnavensc appears to have fastidious growth 
requireiiients when routine iiiycobacteriologic culture methods are 
used. We optimized the growth conditions for M .  ~qenavenre, using 
nude mice previously infected with various M .  genaiiensc. strains. The 
inhibitory effects ofneutral pH, POES and PANTA in the UACTEC 
Systcni were demonstrated. Optimal growth was obtained at pH 6.0 
without additives. The impact of various decontamination pro- 
cedures was also investigated; NALC-NaOH was the least toxic but 
still resulted in loss of viability of at least 100-fold. M.  genavenre was 
then demonstrated to be a micro-aeophilic organism, using a senii- 
solid medium. Furthermore, using low oxygen tensions (i.e. 2.5% or 
5% 0 2 )  rather than the standard 21% 0 2  in the headspace of 
BACTEC bottles, very low inocula (1.e. 25 bacilli/mL) of M.  
Xenautrrsr' could be recovered in primary cultures. A solid inediuni 
(Middlebrook 7H 11) of acid pH and containing charcoal and blood 
also proved usefiil for the culture of A4. .qenavense from clinical 
specimens. The micro-aerophilic nature of M.  Xenavcnse and other 
iiiycobacteria has iiiiportant implications for optimizing primary 
culture conditions and for the treatment of niycobactcrial diseases. 
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Use of microbiological studies to diagnose 
bacteremias, catheter-related infections and 
lower respiratory tract infections in ICU 
patients 
C. Ruef, A.-M. Kraus, R. Hugelshofer. Unii~ersity Hospital 
Zurich, Zuridr, Sui l r r rhrd  
Objectives: To compare patterns of use of microbiological studies 
to diagnose bacteremia, catheter-related infections (CRIs) and lower 
respiratory tract infections (LlITIs) in ICU patient\ 
Methods: Procpective surveillance (May 1996 to October 1097) 
of four ICUs (medical, surgical (cardiac, trauma, neurosurgery)) for 
the diagnosis of iiosocornial infections. Registration of micro- 
biological culture,: blood (B), catheter tip (C), tracheal cecretioiir (T) 
Results: Among 1506 patients (1010 males, 487 females; mean 
age 56.2 years; 11 875 patient days) the following iiiean infection 
rates were observed (infections/1000 ICU-days): bacteretiiia 8.3, 
CRI  8.2, LRTI 33.3. Diagnostic effort and yield varied atiioiig ICUs. 
In the medical 1CU an average of 14.1 B were performed per 
docunieiited bacteremia, and in the neurosurgical ICU 89. The yield 
of cultures of T and C also varied between units (no. T/LI<TI): 
medical 3.5, cardiac surgery 9.7, trauina 7.9, neurosurgery 2.9 (iiiean 
6.1). The ratios for diagnosis o f C R l  were (no. UCRl):  medical 9.1, 
cardiac surgery 16.0, trauma 9.4, neurosurgery 1 2 3  (mean 11.1). 
Cultures of B and T were performed with similar frrquency during 
various phases of ICU stay (cultures/lOO days): B nienn 21.3, range 
17.3-21.8; T mean 20.4, range 18.1-23.1. Cultures of C were 
performed more frequently during later phases of ICU stay: days 1-3, 
3.4; days 4-6, 10.8; days 7-14, 18.2; d.iy 14, 15.6. The combined 
diagnostic use (B+C+T/100 days) diffcred markedly between 1CUs: 
medical 49.3, cardiac surgery 84.9, traniiia 35.6, neurosurgery 58.1 
Conclusions: Utilization of microbiological studies to diagnose 
common infections varied markedly between ICU\. Comparisons 
between units are useful to identify best performers arid to educate 
physicians regarding the rational use of diagnostic studies. 
vl A German system for surveillance of surgical 
site infections (SSls) first results and 
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Objectives: In January 1997 a German surveillance system for 
surgical site iiifectioiis (SSIs) was started to found a rcfercnce databacc 
of SSl rates for quality management activities 
Methods: So far, 34 hospitals with 43 departiiients participate in 
the Krankenhautinfektions-Surveillance System (KISS) using the US 
National Nosocomial Infectioiic Surveillance ("IS) System pi-oto- 
col for SSI and the CIIC definitions for nosocoiiiial infections 
Frequently performed operative procedures were celected, and for all 
patientc who undergo one of these procedures (~i=19), ASA score, 
wound classification and duration of operation are documented. 
From the date of the operation uiitil discharge from the hospital, all 
patients are nionitored for the occurrence of a wound infection 
Results: Up to now, 19 951 operations with 580 SSI have been 
collected. The results for cholecystectoiny in comparison to the 
NNIS data are shown below 
6 4  
Risk-Index 0 Risk-Index 1 
chdecrstsctomy N Rate N Rate 
KISS 1191 1,51 474 1,48 
NNlS 16477 0,54 5893 081 
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Risk-Index 2 Risk-Index 3 
N Rate N Rate 
359 362 171 585 
5554 2,25 2010 3,98 
Table 1 SSI infection rates for cholecystectomy by risk index 
category (NNIS, 10/86-7/97; KISS, 1/97-8/98) 
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Conclusions: These data show that a successful surveillance 
system that provides reliable reference data has been established in 
Germany. A number of quality management activities have been 
started in the participating hospitals, and many more hospitals would 
like to join the project in 1999 
1 1  Diphtheria in Europe 
A. Ektratiou, K.H. Engler, J. Douboyas, C. von Hunolstein, 
J. Vuopio-Varkila, 0. Patey, FA.D. Grimont. PHLS-Re$piratury and 
Systemic Infection Laboratory, Londurz, UK 
Objectives: Within the remit of the European Commission DGXII, 
BioMed 2 programme (1998-2001), to form a network of 
Diphtheria Reference Centres within Europe, so as to improve 
communication and exchange of information between countries on 
the epidemiology and microbiology of infections caused by 
Corynebacterium diphtheriae and C. ulcerans 
Methods: This has been achieved by the award of a DGXII grant 
from the European Commission, the effective collaboration of coun- 
tries within and external to Europe, along with the standardization 
of methodologies and protocols for microbiological surveillance of 
diphtheria. An international quality assurance scheme for laboratory 
performance in diagnostic and typing methodologies has been 
established in order to monitor these activities 
Results: The formation of Diphtheria Reference Centres within 
member states provides the basis for rapid exchange of information 
between countries and the availability of facilities for the micro- 
biological diagnosis of diphtheria. Established centers exist in the UK 
and Finland, with new centers currently being established in France, 
Greece and Italy Epidemiologic and molecular typing databases have 
also been developed for the identification and verification of new and 
existing strains that have the potential to cause epidemics; this is 
crucial for the monitoring and elimination of this resurgent disease 
from the European region 
Conclusions: As diphtheria declines within Europe, accurate, 
sensitive and specific laboratory confirmation of suspect cases 
becomes even more important and highlights the need for countries 
to maintain and increase both clinical and laboratory awareness. 
ESBL-Ea outbreak characterization 
C. Ardanuy, M. Pujol, M.A. Dominguez, E Tubau, J. Ariza, 
J. Lifiares. Hospital de Belluifge, Microbiolugy, Barcelona, Spain 
During a 6-week period (September to November 1997), 18 extended- 
spectrum /?-lactamase-producing Enterobacter aerogenes (ESBL-Ea) 
strains were isolated in clinical samples from five ICU patients. Three 
patients developed bacteremia, one a surgical wound infection and 
one colonization of the respiratory tract. The prior ICU average 
patient stay was 27.8 days, with all patients receiving prior cephalo- 
sporin therapy. The emergence of ESBL-Ea was coincidental with a 
substantial increase in the use of fourth-generation cephalosporins 
(4GC) in previous months. All the isolates were resistant to 
ceftazidime, cefotaxime, aztreonam, tobramycin, ciprofloxacin, tetra- 
cycline and co-trimoxazole, and susceptible to imipenem, gentamicin 
and amikacin by the microdilution method. ESBL production was 
detected by double disk diffusion test, but the ESBL Etest failed to 
detect it. Two b-lactamases of PI 6.5 and PI 8.5 were detected by 
isoelectric focusing analysis of enzymatic extracts. The PI 6.5 b- 
lactamase could be transferred by conjugation, conferring an ESBL 
resistance phenotype to transconjugants. The PI 8.2 b-lactamase 
could not be transferred; therefore, it was considered to be chmmo- 
somal. The ESBL was included in the TEM family by PCR. Geno- 
typic characterization showed a single clone by pulsed-field gel 
electrophoresis, and an identical plasmid profile in all the isolates. 
After introduction of isolation measures and 4GC restriction, no new 
cases of infection or colonization by the epidemic strain were 
detected. The conclusion is that the clustered infections due to 
iiiultiresistant Ea observed were caused by the spreading of an 
epidemic clone TEM-type ESBL producer, and disappeared after 
implementation of isolation measures and reduction of 4GC 
consumption. 
Fungal diseases: diagnosis, virulence factors, 
antifungal agents 
vl Comparative evaluation of PCR and serology 
for diagnosis of aspergillosis in patients with 
hematologic malignancies 
J. Roth', E. Engelmannz, M. Mielke*, D. Huhn', M. Ruhnke'. 
'Department of Hematology and Oncology, Charite', HU-Berlin, 
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Objectives: In this study we compared the diagnostic value of two 
different methods that both promise to provide early and sensitive 
detection of invasive aspergillosis (IA) 
Methods: We used a PCR-based method which amplifies a 
fungus-specific 18s rRNA fragment with subsequent species-specific 
hybridization (according to Einsele et al; DNA extraction had been 
modified) as well as the Platelia Aspergillus antigen detection system 
(Sanofi Pasteur). Within a period of 18 months, blood and BAL (if 
available) of 34 patients with hematologic malignancies (NHL, n=7; 
AML, n=18; ALL, n = 3 ;  CML, n=6) were prospectively sampled 
once or twice a week during hospital stay and processed as described 
above (samples: n=226 ). Sixteen patients showed no clinical or 
laboratory evidence for IA (group A), and 12 patients had clinical and 
radiologic signs of probable IA (group B). Group C was composed 
ofsix patients with proven IA (five histologically proven, one positive 
in repeated BAL) 
Conclusion: The Platelia test appeared to provide more 
conclusive results in proven IA than the PCR-based method. 
Diagnosis in invasive pulmonary aspergillosis, 
an animal model 
M. Becker, S. de Marie, D. Willemse, I.A.J.M. Bakker- 
Woudenberg, Erasmus Med. Center Rotterdam, Med. Microbiology 6 
l n j  Diseases, Rotterdam, The  Netherlands 
Objective: Two diagnostic tests, ELISA for circulating galacto- 
mannan and PCR, were compared for diagnosing and monitoring 
invasive pulmonary aspergillosis in an animal model 
Methods: In a model of invasive left-sided pulmonary aspergillosis 
in persistently neutropenic rats, dissection was performed on day 1, 
day 3, day 5 and day 7 (n=20 each day) after inoculation. Within 
blood samples, PCR as well as ELISA was performed. Fungal 
